Global Radiopharmaceuticals Market By Type (Diagnostic Radioisotopes, and Therapeutic Radioisotopes), By Application (Oncology, and Cardiology), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 134685
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Radiopharmaceuticals Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global radiopharmaceuticals market is segmented on the basis of Type, Application and geography.
The global Radiopharmaceuticals market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Radiopharmaceuticals Market Scope:
By type, the market is segmented into Diagnostic Radioisotopes?and Therapeutic Radioisotopes. By Application, the market is divided into Oncology?and Cardiology. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator?Application, SIEMENS, Dongcheng and Navidea.
Key Market Segments
Type
Diagnostic Radioisotopes
Therapeutic RadioisotopesApplication
Oncology
CardiologyKey Market Players included in the report:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator?Application
SIEMENS
Dongcheng
NavideaReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Radiopharmaceuticals Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Radiopharmaceuticals Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Radiopharmaceuticals Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Radiopharmaceuticals Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Radiopharmaceuticals Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Radiopharmaceuticals Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Radiopharmaceuticals sub-markets, depending on key regions (various vital states).
To analyze Radiopharmaceuticals Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Radiopharmaceuticals Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Radiopharmaceuticals Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Radiopharmaceuticals Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Radiopharmaceuticals Market Overview3.1. Radiopharmaceuticals Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Radiopharmaceuticals Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Radiopharmaceuticals Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Diagnostic Radioisotopes
4.4. Therapeutic Radioisotopes5. Global Radiopharmaceuticals Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Radiopharmaceuticals Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Oncology
5.4. Cardiology6. Global Radiopharmaceuticals Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Radiopharmaceuticals Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Radiopharmaceuticals Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Radiopharmaceuticals Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Radiopharmaceuticals Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Radiopharmaceuticals Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA -
Inquiry Before Buying
-
Request Sample
